Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor

Molecular Medicine Reports

Volumn 9, Issue 2, 2014, Pages 583-589

  Dong, Jing ^a   Cheng, Mingjun ^a   Sun, Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cervical cancer cell; Inducible nitric oxide synthase; Proliferation; Vascular endothelial growth factor

Indexed keywords

CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893852933     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1838     Document Type: Article

References (19)

1. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
2. Bosch FX, Manos MM, Munoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802, 1995.
3. Dürst M, Gissmann L, Ikenberg H and zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812-3815, 1983.
4. Bosch FX, Lorincz A, Muñoz N, Meijer CJ and Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265, 2002.
5. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340: 1137-1143, 1999.
6. Isacson C, Kessis TD, Hedrick L and Cho KR: Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 56: 669-674, 1996.
7. Tsang RW, Fyles AW, Li Y, et al: Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables. Radiother Oncol 50: 85-92, 1999.
8. Lo HW, Hsu SC, Ali-Seyed M, et al: Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7: 575-589, 2005.
9. Kroll J and Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998.
10. Ichinoe M, Mikami T, Shiraishi H and Okayasu I: High microvascular density is correlated with high VEGF, iNOS and COX-2 expression in penetrating growth-type early gastric carcinomas. Histopathology 45: 612-618, 2004.
11. Zhang J and Peng B: NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro. Cell Prolif 42: 150-161, 2009.
12. Saura M, Zaragoza C, McMillan A, et al: An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10: 21-28, 1999.
13. Kostourou V, Cartwright JE, Johnstone AP, et al: The role of tumour-derived iNOS in tumour progression and angiogenesis. Br J Cancer 104: 83-90, 2011.
14. Benjamin LE, Hemo I and Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598, 1998.
15. Holash J, Davis S, Papadopoulos N, et al: VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 99: 11393-11398, 2002.
16. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S and Xie XJ: Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2: 8, 2002.
17. Chiarugi V, Magnelli L and Gallo O: Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review). Int J Mol Med 2: 715-724, 1998.
18. Martínez-Estrada OM, Rodríguez-Millán E, González-De Vicente E, Reina M, Vilaró S and Fabre M: Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18: 2538-2544, 2003.
19. Fukumura D and Jain RK: Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 74: 72-84, 2007.